再生醫學:應用於骨骼和關節
市場調查報告書
商品編碼
1284954

再生醫學:應用於骨骼和關節

Regenerative Medicines: Bone and Joint Applications

出版日期: | 出版商: BCC Research | 英文 147 Pages | 訂單完成後即時交付

價格

全球骨關節再生醫學市場規模將從2022年的96億美元增長到2023年的107億美元,2023年至2028年的預測期內復合年增長率為12.1%,到2028年預計增長2018 年增至 189 億美元。

到 2028 年,生物材料技術行業的規模預計將從 2023 年的 64 億美元增長到 110.3 億美元,複合年增長率為 11.3%。 組織工程領域也有望從 2023 年的 27 億美元增長到 2028 年的 50.4 億美元,複合年增長率為 13.3%。

在這份報告中,我們研究了全球骨關節再生醫學市場、市場和技術背景、市場影響因素和市場機會分析、監管環境、市場規模趨勢和預測、各個細分市場和地區。它總結了其他詳細分析、專利動向、競爭環境、各大企業概況等。

內容

第一章介紹

第 2 章要點摘要

第三章市場與技術背景

  • 再生醫學概述
  • 再生醫學如何運作?
  • 再生醫學的主要方法
  • 細胞和組織
  • 組織工程
  • 支架在組織工程中的重要性
  • 塑料腳手架
  • 血管支架
  • CIMIT(醫學與創新技術整合中心)
  • 胚胎幹細胞

第 4 章市場中的新興/未來技術

  • 最新技術在骨骼和關節再生醫學中的應用
  • 整形外科中的納米材料和再生醫學
  • 使用乾細胞和納米技術的再生醫學
  • 納米結構軟骨組織工程
  • 骨組織工程
  • 肌腱組織工程
  • 脂肪組織
  • 富血小板血漿 (PRP)
  • 用於構建多細胞/多物質組織的生物打印技術
  • 組織工程中的支架選項
  • 水凝膠支架
  • 堅固的腳手架
  • 未來的機會

第 5 章市場動態

  • 市場驅動因素
  • 市場製約因素
  • 市場機會
  • COVID-19 影響分析

第 6 章市場細分:按技術

  • 世界市場:按技術分類
  • 生物材料
  • 可回收生物材料
  • 市場規模和預測
  • 組織工程
  • 市場規模和預測
  • 幹細胞療法
  • 市場規模和預測

第 7 章市場細分:按應用

  • 世界市場:按應用分類
  • 同種異體骨
  • 市場規模和預測
  • 自體骨
  • 市場規模和預測
  • 骨移植替代物
  • 市場規模和預測
  • 骨骼和關節疾病
  • 市場規模和預測
  • 其他疾病
  • 市場規模和預測

第 8 章市場細分:按地區

  • 世界市場:按地區
  • 北美
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 俄羅斯
  • 西班牙
  • 其他歐洲
  • 亞太地區
  • 中國
  • 日本
  • 澳大利亞
  • 印度
  • 亞太其他地區
  • 其他地區
  • 市場規模和預測

第 9 章監管環境

  • 骨關節再生醫學新審批及加速審批

第10章專利審查與新發展

第11章競爭格局

  • 併購/合同
  • 產品發布
  • 製造商和市場份額分析

第12章公司簡介

  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BAXTER INTERNATIONAL INC.
  • BIOVENTUS
  • CONMED CORP.
  • DEPUY SYNTHES PRODUCTS INC.
  • MEDTRONIC PLC
  • ROYAL BIOLOGICS
  • SEIKAGAKU CORP.
  • SMITH & NEPHEW PLC
  • STRYKER CORP.
  • ZIMMER BIOMET HOLDINGS INC.

第 13 章附錄:縮略詞列表

Product Code: PHM032F

Highlights:

The global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.

The biomaterials technology segment in the global market for regenerative medicine in bone and joint applications is estimated to increase from $6.4 billion in 2023 to $11.03 billion by 2028, at a CAGR of 11.3% from 2023 through 2028.

The tissue engineering segment in the global market for regenerative medicine in bone and joint applications is estimated to increase from $2.7 billion in 2023 to $5.04 billion by 2028, at a CAGR of 13.3% from 2023 through 2028.

Report Scope:

The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.

This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.

The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases, and others.

The report provides information to all market players, potential entrants, government agencies, and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Report Includes:

  • 36 data tables and 30 additional tables
  • An up-to-date review and in-depth assessment of the global markets for regenerative medicine in bone and joint applications
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for regenerative medicine for bone and joint applications market, and corresponding market share analysis based on the type of technology, application, and region
  • Highlights of the importance of biomaterials, stem cell therapy, tissue engineering, and emerging/upcoming technologies (including bioprinting) in the regenerative medicine industry, along with the long-term impacts of regenerative medicine technologies, both existing and in developmental stage
  • Country specific data analysis and market growth forecasts for the U.S., Canada, Germany, the UK, France, Italy, Russia, Spain, Australia, Japan, China and India
  • Discussion of major growth drivers and restraints, technology advancements, product innovations and regulatory aspects that will shape the market for regenerative medicine for bone and joint applications as a basis for projecting demand in the next few years (2023-2028)
  • Identification of the companies best positioned to meet this demand owing to or in conjunction with their proprietary technologies, product launches, and other strategic advantages
  • Holistic review of the impact of COVID-19 and other economic and demographic factors affecting the market growth in the analysis period
  • A relevant patent analysis with the number of patents registered/approved, ongoing industry clinical trials, and recent mergers, acquisitions, and collaboration agreements in the regenerative medicine industry
  • Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on global R&D activities, market growth strategies, and company revenue share analysis
  • Identification of leading and emerging competitors in the global regenerative medicine market, and analysis of competitive landscape based on recent developments and segmental revenues
  • Company profiles descriptions of the major market players, including Smith & Nephew Plc, DePuy Synthes, Medtronic plc, Stryker Corp., Bioventus, Zimmer Biomet, Anika Therapeutics, Baxter Intl., and CONMED Corp.

Table of Contents

Chapter 1 Introduction

  • Background
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • What's New in This Update?
  • Scope of Report
  • Information Sources
  • Research Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Overview of Regenerative Medicine
  • How Regenerative Medicine Works?
  • Principal Approaches to Regenerative Medicine
  • Cells and Tissues
  • Tissue Engineering
  • Importance of Scaffolding in Tissue Engineering
  • Plastic Scaffolding
  • Blood Vessel Scaffolding
  • Center for Integration of Medicine and Innovative Technology (CIMIT)
  • Embryonic Stem Cells

Chapter 4 Emerging/Upcoming Technologies in the Market

  • Emerging Technologies in Regenerative Medicines for Bones and Joint Applications
  • Nanomaterials and Regenerative Medicine in Orthopedic Surgery
  • Regeneration Therapy Using Stem Cells and Nanometer Technology
  • Nanostructured Cartilage Tissue Engineering
  • Bone Tissue Engineering
  • Tendon Tissue Engineering
  • Adipose Tissue
  • Platelet-Rich-Plasma (PRP)
  • Bioprinting Technologies for Construction of Multicellular/Multi-material Tissues
  • Scaffolding Option in Tissue Engineering
  • Hydrogel Scaffold
  • Solid Scaffold
  • Future Opportunities

Chapter 5 Market Dynamics

  • Market Drivers
  • Growing Number of Bone and Joint Disorders and Orthopedic Surgeries
  • Increasing Expenditures for Health Care and Investments in Regenerative Medicines
  • Increasing Geriatric Population
  • Increasing Product Approvals and Launches
  • R&D for Stem and Gene Therapies
  • Market Restraints
  • Stringent Government Regulatory Settings in R&D
  • Market Opportunities
  • Growing Pipeline for Regenerative Medicines
  • COVID-19 Impact Analysis
  • Impact of COVID-19 on the Market for Cell and Gene Therapies and Regenerative Medicine for Bone and Joint Applications
  • Direct Impact on Clinical Trials in Cell and Gene Therapy
  • Post-COVID-19 Effect on Regenerative Medicine for Bones and Joint Applications

Chapter 6 Market Breakdown by Technology

  • Global Market, by Technology
  • Biomaterials
  • Biomaterials for Regeneration
  • Market Size and Forecast
  • Tissue Engineering
  • Market Size and Forecast
  • Stem Cell Therapy
  • Market Size and Forecast

Chapter 7 Market Breakdown by Application

  • Global Market, by Application
  • Allogeneic Bones
  • Market Size and Forecast
  • Autogenic Bones
  • Market Size and Forecast
  • Bone Graft Substitutes
  • Market Size and Forecast
  • Osteoarticular Diseases
  • Market Size and Forecast
  • Other Diseases
  • Market Size and Forecast

Chapter 8 Market Breakdown by Region

  • Global Market, by Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Russia
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia-Pacific
  • Rest of the World
  • Market Size and Forecast

Chapter 9 Regulatory Aspects

  • New and Accelerated Approvals of Regenerative Medicine for Bones and Joint Applications

Chapter 10 Patent Review/New Developments

  • Patent Analysis, by Year

Chapter 11 Competitive Landscape

  • Mergers, Acquisitions, and Agreements
  • Product Launches
  • Manufacturers of Regenerative Medicine for Bones and Joint Applications and their Market Share Analysis

Chapter 12 Company Profiles

  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BAXTER INTERNATIONAL INC.
  • BIOVENTUS
  • CONMED CORP.
  • DEPUY SYNTHES PRODUCTS INC. (PART OF JOHNSON & JOHNSON)
  • MEDTRONIC PLC
  • ROYAL BIOLOGICS
  • SEIKAGAKU CORP.
  • SMITH & NEPHEW PLC
  • STRYKER CORP.
  • ZIMMER BIOMET HOLDINGS INC.

Chapter 13 Appendix: List of Acronyms

List of Tables

  • Summary Table B : Global Market for Regenerative Medicine in Bone and Joint Applications, by Region, Through 2028
  • Summary Table A : Global Market for Regenerative Medicine in Bone and Joint Applications, by Technology, Through 2028

Table A : Newly Added Chapters

  • Table 1 : List of Developed Organoids from Various Body Organs
  • Table 2 : Cumulative Number of Hip and Knee Procedures Performed, 2012-2021
  • Table 3 : Global Market for Regenerative Medicine in Bone and Joint Applications, by Technology, Through 2028
  • Table 4 : Biomaterial-Assisted Gene Therapy in Musculoskeletal Research
  • Table 5 : Global Market for Biomaterials in Bone and Joint Applications, by Region, Through 2028
  • Table 6 : Biomaterials Utilized for Specific Target Tissues and Cell Types
  • Table 7 : Global Market for Tissue Engineering in Bone and Joint Applications, by Region, Through 2028
  • Table 8 : Global Market for Stem Cell Therapy in Bone and Joint Applications, by Region, Through 2028
  • Table 9 : Global Market for Regenerative Medicine in Bone and Joint Applications, by Application Type, Through 2028
  • Table 10 : Global Market for Regenerative Medicine in Allogeneic Bones Grafting Applications, by Region, Through 2028
  • Table 11 : Global Market for Regenerative Medicine in Autogenic Bones Grafting Applications, by Region, Through 2028
  • Table 12 : Global Market for Regenerative Medicine in Bone Graft Substitutes Applications, by Region, Through 2028
  • Table 13 : Global Market for Regenerative Medicine in Osteoarticular Disease Applications, by Region, Through 2028
  • Table 14 : Global Market for Regenerative Medicine in Other Diseases Applications, by Region, Through 2028
  • Table 15 : Global Market for Regenerative Medicine in Bone and Joint Applications, by Region, Through 2028
  • Table 16 : North American Market for Regenerative Medicine in Bone and Joint Applications, by Technology, Through 2028
  • Table 17 : North American Market for Regenerative Medicine in Bone and Joint Applications, by Country, Through 2028
  • Table 18 : European Market for Regenerative Medicine in Bone and Joint Applications, by Technology, Through 2028
  • Table 19 : European Market for Regenerative Medicine in Bone and Joint Applications, by Country, Through 2028
  • Table 20 : Asia-Pacific Market for Regenerative Medicine in Bone and Joint Applications, by Technology, Through 2028
  • Table 21 : Asia-Pacific Market for Regenerative Medicine in Bone and Joint Applications, by Country, Through 2028
  • Table 22 : RoW Market for Regenerative Medicine in Bone and Joint Applications, by Technology, Through 2028
  • Table 23 : New and Accelerated Approvals of Regenerative Medicine for Bones and Joint Applications, 2018-2023
  • Table 24 : Patents Registered/Approved on Regenerative Medicine in Bone and Joint Applications, by Assignee Country, 2020-March 2023
  • Table 25 : Patents Granted on Regenerative Medicine in Bone and Joint Applications, by Year, 2020-March 2023
  • Table 26 : Major Patents on Regenerative Medicine in Bone and Joint Applications, 2022-March 2023
  • Table 27 : Recent Mergers, Acquisitions, and Agreements in the Global Regenerative Medicine Market, 2018-2023
  • Table 28 : Recently Launched Products, Global Regenerative Medicine Market, 2018-2023
  • Table 29 : Anika Therapeutics: R&D Expenditures, 2020-2022
  • Table 30 : Anika Therapeutics: Products Offered
  • Table 31 : Anika Therapeutics: Recent Developments, 2019-2023
  • Table 32 : Arthrex Inc.: Products Offered
  • Table 33 : Arthrex Inc.: Recent Developments, 2020-2023
  • Table 34 : Boxer International: R&D Expenditures, 2020-2022
  • Table 35 : Baxter International: Products Offered
  • Table 36 : Baxter International: Recent Developments, 2020-2023
  • Table 37 : Bioventus: R&D Expenditures, 2020-2022
  • Table 38 : Bioventus: Products Offered
  • Table 39 : Bioventus: Recent Developments, 2019-2022
  • Table 40 : CONMED Corp.: R&D Expenditures, 2020-2022
  • Table 41 : CONMED Corp.: Products Offered
  • Table 42 : CONMED Corp.: Recent Developments, 2022
  • Table 43 : Johnson & Johnson (DePuy Synthes Companies, MedTech): R&D Expenditures, 2020-2022
  • Table 44 : Johnson & Johnson (DePuy Synthes Companies): Products Offered
  • Table 45 : Johnson & Johnson (DePuy Synthes Companies): Recent Developments, 2017-2022
  • Table 46 : Medtronic plc: R&D Expenditures, 2020-2022
  • Table 47 : Medtronic plc: Products Offered
  • Table 48 : Medtronic plc: Recent Developments, 2018-2019
  • Table 49 : Royal Biologics: Products Offered
  • Table 50 : Royal Biologics: Recent Developments, 2020-2022
  • Table 51 : Seikagaku Corp.: R&D Expenditures, 2020-2022
  • Table 52 : Seikagaku Corp.: Products Offered
  • Table 53 : Seikagaku Corp.: Recent Developments, 2019-2021
  • Table 54 : Smith & Nephew plc: R&D Expenditures, 2020-2022
  • Table 55 : Smith & Nephew plc: Products Offered
  • Table 56 : Smith & Nephew plc: Recent Developments, 2019-2022
  • Table 57 : Stryker Corp.: R&D Expenditures, 2020-2022
  • Table 58 : Stryker Corp.: Products Offered
  • Table 59 : Stryker Corp.: Recent Developments, 2020-2022
  • Table 60 : Zimmer Biomet Holdings: R&D Expenditures, 2020-2022
  • Table 61 : Zimmer Biomet Holdings: Products Offered
  • Table 62 : Zimmer Biomet Holdings: Recent Developments, 2022-2023
  • Table 63 : Acronyms Used in This Report

List of Figures

  • Summary Figure A : Global Market Shares of Regenerative Medicine in Bone and Joint Applications, by Technology, 2022
  • Summary Figure B : Global Market for Regenerative Medicine in Bone and Joint Applications, by Region, 2020-2028
  • Figure 1 : Emerging Technologies in Regenerative Medicines for Bones and Joint Applications
  • Figure 2 : Shares of Platelet-Rich Plasma (PRP) Trials, by Segment, Feb. 2022-Feb. 2023
  • Figure 3 : Shares of the Global Health Expenditure Database, by Select Country, 2022
  • Figure 4 : Global Aging (65 and Over) Population, by Region, 2019 and 2050
  • Figure 5 : Global Market for Regenerative Medicine in Bone and Joint Applications, by Technology, 2020-2028
  • Figure 6 : Global Market Shares of Regenerative Medicine in Bone and Joint Applications, by Technology, 2022
  • Figure 7 : Global Market for Regenerative Medicine for Biomaterials in Bone and Joint Applications, 2020-2028
  • Figure 8 : Global Market for Biomaterials in Bone and Joint Applications, by Region, 2020-2028
  • Figure 9 : Global Market for Tissue Engineering in Bone and Joint Applications, 2020-2028
  • Figure 10 : Global Market for Tissue Engineering in Bone and Joint Applications, by Region, 2020-2028
  • Figure 11 : Global Market for Stem Cell Therapy in Bone and Joint Applications, 2020-2028
  • Figure 12 : Global Market for Stem Cell Therapy in Bone and Joint Applications, by Region, 2020-2028
  • Figure 13 : Global Market Shares of Regenerative Medicine in Bone and Joint Applications, by Type, 2022
  • Figure 14 : Global Market for Regenerative Medicine in Allogeneic Bones Grafting Applications, 2020-2028
  • Figure 15 : Global Market for Regenerative Medicine in Allogeneic Bones Grafting Applications, by Region, 2020-2028
  • Figure 16 : Global Market for Regenerative Medicine in Autogenic Bones Grafting Applications, 2020-2028
  • Figure 17 : Global Market for Regenerative Medicine in Autogenic Bones Grafting Applications, by Region, 2020-2028
  • Figure 18 : Global Market for Regenerative Medicine in Bone Graft Substitutes Applications, 2020-2028
  • Figure 19 : Global Market for Regenerative Medicine in Bone Graft Substitutes Applications, by Region, 2020-2028
  • Figure 20 : Global Market for Regenerative Medicine in Osteoarticular Disease Applications, 2020-2028
  • Figure 21 : Global Market for Regenerative Medicine in Osteoarticular Disease Applications, by Region, 2020-2028
  • Figure 22 : Global Market for Regenerative Medicine in Other Diseases Applications, 2020-2028
  • Figure 23 : Global Market for Regenerative Medicine in Other Diseases Applications, by Region, 2020-2028
  • Figure 24 : Global Market for Regenerative Medicine in Bone and Joint Applications, by Region, 2020-2028
  • Figure 25 : Global Market Shares of Regenerative Medicine in Bone and Joint Applications, by Region, 2022
  • Figure 26 : North American Market Shares of Regenerative Medicine in Bone and Joint Applications, by Technology, 2022
  • Figure 27 : North American Market Shares of Regenerative Medicine in Bone and Joint Applications, by Country, 2022
  • Figure 28 : U.S. Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 29 : Canadian Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 30 : European Market Shares of Regenerative Medicine in Bone and Joint Applications, by Technology, 2022
  • Figure 31 : European Market Shares of Regenerative Medicine in Bone and Joint Applications, by Country, 2022
  • Figure 32 : German Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 33 : French Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 34 : U.K. Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 35 : Italian Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 36 : Russian Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 37 : Spanish Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 38 : Rest of European Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 39 : Asia-Pacific Market Shares of Regenerative Medicine in Bone and Joint Applications, by Technology, 2022
  • Figure 40 : Asia-Pacific Market Shares of Regenerative Medicine in Bone and Joint Applications, by Country, 2022
  • Figure 41 : Chinese Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 42 : Japanese Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 43 : Australian Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 44 : Indian Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 45 : Rest of Asia-Pacific Market for Regenerative Medicine in Bone and Joint Applications, 2020-2028
  • Figure 46 : RoW Market Shares of Regenerative Medicine in Bone and Joint Applications, by Technology, 2022
  • Figure 47 : Shares of Patents Registered/Approved on Regenerative Medicine in Bone and Joint Applications, by Assignee Country, 2020-March 2023
  • Figure 48 : Global Market Shares Regenerative Medicine in Bone and Joint Applications, by Key Players, 2022
  • Figure 49 : Anika Therapeutics: Net Revenue, 2018-2022
  • Figure 50 : Anika Therapeutics: Revenue Share, by Business Segment, 2022
  • Figure 51 : Anika Therapeutics: Revenue Share, by Region/Country, 2022
  • Figure 52 : Baxter International: Net Revenue, 2018-2022
  • Figure 53 : Baxter International: Revenue Share, by Business Segment, 2022
  • Figure 54 : Baxter International: Revenue Share, by Region, 2022
  • Figure 55 : Bioventus: Net Revenue, 2018-2022
  • Figure 56 : Bioventus: Revenue Share, by Business Segment, 2022
  • Figure 57 : Bioventus: Revenue Share, by Region, 2022
  • Figure 58 : CONMED Corp.: Net Revenue, 2018-2022
  • Figure 59 : CONMED Corp.: Revenue Share, by Business Segment, 2022
  • Figure 60 : CONMED Corp.: Revenue Share, by Region, 2022
  • Figure 61 : Johnson & Johnson (DePuy Synthes Companies): Net Revenue, 2018-2022
  • Figure 62 : Johnson & Johnson (DePuy Synthes): Revenue Share, by Business Segment, 2022
  • Figure 63 : Johnson & Johnson (DePuy Synthes Companies): Revenue Share, by Region, 2022
  • Figure 64 : Medtronic plc: Net Revenue, 2018-2022
  • Figure 65 : Medtronic plc: Revenue Share, by Business Segment, 2022
  • Figure 66 : Medtronic plc: Revenue Share, by Region, 2022
  • Figure 67 : Seikagaku Corp.: Net Revenue, 2018-2022
  • Figure 68 : Seikagaku Corp.: Revenue Share, by Business Segment, 2022
  • Figure 69 : Smith & Nephew plc: Net Revenue, 2018-2022
  • Figure 70 : Smith & Nephew plc: Revenue Share, by Business Segment, 2022
  • Figure 71 : Smith & Nephew plc: Revenue Share, by Region, 2022
  • Figure 72 : Stryker Corp.: Net Revenue, 2018-2022
  • Figure 73 : Stryker Corp.: Revenue Share, by Business Segment, 2022
  • Figure 74 : Stryker Corp.: Revenue Share, by Region, 2022
  • Figure 75 : Zimmer Biomet Holdings: Net Revenue, 2018-2022
  • Figure 76 : Zimmer Biomet Holdings: Revenue Share, by Business Segment, 2022
  • Figure 77 : Zimmer Biomet Holdings: Revenue Share, by Region, 2022